Table 2.
Roles of ALKBH1 in human non-cancer diseases.
| Diseases type | Expression | Modification types | Modification expression in diseases | Biological functions | Molecular mechanisms | Targets | Reference |
|---|---|---|---|---|---|---|---|
| CKD | up | DNA 6mA | down | Aggravating medial vascular calcification (VC) progression and osteogenic reprogramming | Facilitating the binding of octamer-binding transcription factor 4 (Oct4) to the bone morphogenetic protein 2 (BMP2) promoter and activates BMP2 transcription | BMP2 | 98 |
| Hypertension | up | DNA 6mA | down | Angiotensin II-induced vascular remodeling | Regulating hypoxia-inducible factor 1α (HIF1α) | HIF1α | 100 |
| AS | up | DNA 6mA | down | Promoting the oncogenic role of the hypoxia-response gene myocardial infarction-associated transcript (MIAT) | Facilitating HIF1α binding and activation of MIAT | HIF1α | 107 |
| AAA | down | m1A | No study | No study | No study | No study | 111 |